GLAND.NS Gland Pharma Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 165191 | 96955 | 58.69% |
| 2026-08-27 | 129706 | 61236 | 47.21% |
| 2026-08-26 | 360874 | 209702 | 58.11% |
| 2026-08-25 | 139251 | 54367 | 39.04% |
| 2026-08-24 | 517520 | 309249 | 59.76% |
| 2026-08-21 | 244651 | 113222 | 46.28% |
| 2026-08-20 | 563338 | 389005 | 69.05% |
| 2026-08-19 | 254909 | 133000 | 52.18% |
| 2026-08-18 | 488656 | 346597 | 70.93% |
| 2026-08-17 | 372430 | 159558 | 42.84% |
| 2026-08-14 | 789574 | 368295 | 46.64% |
| 2026-08-13 | 793051 | 358824 | 45.25% |
| 2026-08-12 | 732471 | 256488 | 35.02% |
| 2026-08-11 | 8760097 | 1328146 | 15.16% |
| 2026-08-10 | 720772 | 426998 | 59.24% |
| 2026-08-07 | 317731 | 192841 | 60.69% |
| 2026-08-06 | 503618 | 258103 | 51.25% |
| 2026-08-05 | 299935 | 180217 | 60.09% |
| 2026-08-04 | 765513 | 455683 | 59.53% |
| 2026-08-03 | 502554 | 297486 | 59.19% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers GLAND.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 11 Feb 2026 | A. JAYATHEERTHA | Employees/Designated Employees | Sell | Market Sale | 100 | 188800 | 0.00% | XBRL |
| 05 Feb 2026 | P LAKSHMI NARAYANA | Employees/Designated Employees | Sell | Market Sale | 800 | 1488800 | 0.00% | XBRL |
| 05 Feb 2026 | A. JAYATHEERTHA | Employees/Designated Employees | Sell | Market Sale | 306 | 588132 | 0.00% | XBRL |
| 25 Nov 2025 | P LAKSHMI NARAYANA | Employees/Designated Employees | Sell | Market Sale | 300 | 540845 | 0.00% | XBRL |
| 29 Sep 2025 | A. JAYATHEERTHA | Employees/Designated Employees | Sell | Market Sale | 325 | 662350 | 0.00% | XBRL |
| 29 Sep 2025 | A. JAYATHEERTHA | Employees/Designated Employees | Sell | Market Sale | 191 | 379879 | 0.00% | XBRL |
| 26 Feb 2025 | S SRINIVASA RAO | Employees/Designated Employees | Buy | ESOP | 2800 | 1517600 | 0.00% | XBRL |
| 28 Jun 2024 | BH LENIN KUMAR RAJA | Employees/Designated Employees | Sell | Market Sale | 1400 | 2531000 | 0.00% | XBRL |
| 28 Jun 2024 | RONG WU | Employees/Designated Employees | Sell | Market Sale | 5792 | 10360568 | 0.00% | XBRL |
| 28 Jun 2024 | S SRINIVASA RAO | Employees/Designated Employees | Sell | Market Sale | 1950 | 3533946 | 0.00% | XBRL |
| 28 Jun 2024 | P B Ravindra Varma | Employees/Designated Employees | Sell | Market Sale | 1950 | 3529500 | 0.00% | XBRL |
| 28 Jun 2024 | P B Ravindra Varma | Employees/Designated Employees | Sell | Market Sale | 2000 | 3649840 | 0.00% | XBRL |
| 28 Jun 2024 | S SRINIVASA RAO | Employees/Designated Employees | Sell | Market Sale | 1000 | 1822000 | 0.00% | XBRL |
| 28 Jun 2024 | RONG WU | Employees/Designated Employees | Sell | Market Sale | 6182 | 11252809 | 0.00% | XBRL |
| 26 Jun 2024 | PRAKASH BALIGA | Employees/Designated Employees | Sell | Market Sale | 500 | 908528 | 0.00% | XBRL |
| 26 Jun 2024 | P B Ravindra Varma | Employees/Designated Employees | Sell | Market Sale | 4000 | 7300000 | 0.00% | XBRL |
| 26 Jun 2024 | S SRINIVASA RAO | Employees/Designated Employees | Sell | Market Sale | 1000 | 1825000 | 0.00% | XBRL |
| 26 Jun 2024 | K. RAGHURAMACHANDRA RAO | Employees/Designated Employees | Sell | Market Sale | 1500 | 2737500 | 0.00% | XBRL |
| 26 Jun 2024 | A. JAYATHEERTHA | Employees/Designated Employees | Sell | Market Sale | 968 | 1766600 | 0.00% | XBRL |
| 26 Jun 2024 | BH LENIN KUMAR RAJA | Employees/Designated Employees | Sell | Market Sale | 3000 | 5472000 | 0.00% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers GLAND.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
Eroding
ROCE Trajectory
Earnings Quality
No persistent gap detected
Net Profit CAGR 9.56% vs CFO CAGR 41.50% over 3.0y (2023-03-31 → 2026-03-31); most recent year: Net Profit +47.07% vs CFO +12.75%
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,537.45 Cr. | ₹1,401.71 Cr. | ₹1,405.83 Cr. | ₹1,384.05 Cr. | ₹1,424.91 Cr. | ₹1,505.62 Cr. | ₹1,486.88 Cr. | ₹1,695.36 Cr. | ₹1,742.79 Cr. | ₹1,800.27 Cr. | RevenueFromOperations |
| Net Profit | ₹192.42 Cr. | ₹143.76 Cr. | ₹163.53 Cr. | ₹204.69 Cr. | ₹186.54 Cr. | ₹215.48 Cr. | ₹183.68 Cr. | ₹261.48 Cr. | ₹366.68 Cr. | ₹316.96 Cr. | ProfitOrLossAttributableToOwnersOfParent |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers GLAND.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitOrLossAttributableToOwnersOfParent | 10273160000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 164760000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 75267850000.0 |
| CurrentLiabilities | 16084030000.0 |
| EquityAttributableToOwnersOfParent | 103579500000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 2433600000.0 |